We’ve compiled the essential information pet owners need to know about pimobendan, a medication commonly used in treating heart disease in dogs, in a Q&A format.



| Item | Pimobendan | Digoxin | ACE Inhibitor |
|---|---|---|---|
| Primary Action | Positive inotrope + arterial/venous dilation (inodilator) | Positive inotrope (increases cardiac contractility) | Vasodilation |
| Oxygen Demand | Does not increase | Increases | — |
| Effect on Arrhythmia | No arrhythmia induction at prescribed dose | Veterinary monitoring required | Low |
| Dosing Frequency | Twice daily (approx. 12-hour intervals) | As prescribed by veterinarian | As prescribed by veterinarian |
Pimobendan is recommended as the standard treatment for the asymptomatic stage with left atrial and left ventricular enlargement (ACVIM Stage B2) and for symptomatic Stage C. It is not recommended in the pre-enlargement stage (B1). The timing and method of administration must follow the veterinarian's instructions.

Seek Immediate Veterinary Care for Sudden Breathing Difficulties or Shock Symptoms
If your pet suddenly experiences difficulty breathing, bluish discoloration of the mouth, or collapses while taking Pimobendan, seek veterinary care immediately. These could be signs of a serious adverse reaction, so it’s important to monitor your pet closely during treatment.


A veterinarian who majored in veterinary medicine at Khon Kaen University, Thailand, and completed the IVSA program at North Carolina State University in the United States. Drawing on clinical experience at animal hospitals, he works in the pet healthcare field and is dedicated to building a digital care environment that connects pet parents with veterinarians.
Share
[1] Plumb, D.C. (2023). Plumb's Veterinary Drug Handbook, 10th Edition. Wiley-Blackwell.
[2] Stern, J.A. & Walker, A.L. (2022). Small Animal Critical Care Medicine, 3rd Edition. Elsevier.
[3] Blackwell's Five-Minute Veterinary Consult Clinical Companion, Small Animal Toxicology, 3rd Edition. Wiley-Blackwell, 2021.